Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Axitinib Nitroso Impurity 4

● Auf Lager

Katalog-Nr.::	VE0024259
CAS-Nr.::	N/A
Summenformel::	C15H11IN4O2S
Molare Masse::	438.24 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Axitinib Nitroso Impurity 4

Parent drug

N/A

IUPAC-Name

2-((3-iodo-1-nitroso-1H-indazol-6-yl)thio)-N-methylbenzamide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

IC1=NN(N=O)C2=CC(SC3=CC=CC=C3C(NC)=O)=CC=C21

InChI

InChI=1S/C15H11IN4O2S/c1-17-15(21)11-4-2-3-5-13(11)23-9-6-7-10-12(8-9)20(19-22)18-14(10)16/h2-8H, 1H3, (H, 17, 21)

Beschreibung

Axitinib Nitroso Impurity 4 is an N-nitroso derivative of the secondary amine present | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC). It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.